Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $289.24 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), Inc. | $125.00 | 1 | $0 (2019) |
| Organogenesis Inc. | $79.81 | 1 | $0 (2019) |
| Kerecis Limited | $26.83 | 1 | $0 (2024) |
| Biofrontera Inc. | $20.66 | 1 | $0 (2024) |
| PFIZER INC. | $20.16 | 1 | $0 (2023) |
| DUSA Pharmaceuticals, Inc. | $16.78 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.49 | 2 | Kerecis Limited ($26.83) |
| 2023 | $20.16 | 1 | PFIZER INC. ($20.16) |
| 2019 | $204.81 | 2 | Helsinn Therapeutics (U.S.), Inc. ($125.00) |
| 2018 | $16.78 | 1 | DUSA Pharmaceuticals, Inc. ($16.78) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $26.83 | General |
| Category: Wound Care | ||||||
| 03/18/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: DERMATOLOGY | ||||||
| 05/04/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2019 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2019 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $79.81 | General |
| Category: Wound Care | ||||||
| 12/18/2018 | DUSA Pharmaceuticals, Inc. | BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device), Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 6,529 | 11,449 | $2.5M | $1.0M |
| 2022 | 33 | 6,779 | 12,038 | $2.5M | $1.1M |
| 2021 | 31 | 7,068 | 12,586 | $2.6M | $1.1M |
| 2020 | 34 | 7,022 | 12,615 | $2.6M | $1.1M |
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 483 | 615 | $627,915 | $295,582 | 47.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 148 | 175 | $143,500 | $89,504 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 966 | 1,413 | $158,256 | $88,805 | 56.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 269 | 317 | $260,257 | $65,927 | 25.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 138 | 181 | $118,012 | $61,657 | 52.2% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 69 | 72 | $102,406 | $59,195 | 57.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 259 | 381 | $95,707 | $46,683 | 48.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 839 | 1,265 | $217,997 | $45,139 | 20.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 464 | 551 | $91,934 | $44,715 | 48.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 588 | 726 | $141,570 | $42,883 | 30.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 448 | 629 | $50,471 | $26,217 | 51.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 100 | 107 | $80,250 | $20,654 | 25.7% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 24 | 24 | $36,831 | $20,065 | 54.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 646 | 3,838 | $76,760 | $19,920 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 275 | 275 | $42,408 | $19,505 | 46.0% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 29 | 29 | $28,711 | $18,773 | 65.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 304 | 304 | $38,079 | $15,286 | 40.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 77 | 82 | $28,700 | $11,415 | 39.8% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 51 | 53 | $29,786 | $11,326 | 38.0% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 43 | 52 | $13,639 | $7,636 | 56.0% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 38 | 42 | $10,589 | $6,970 | 65.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 136 | 172 | $35,910 | $6,969 | 19.4% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 27 | 27 | $19,473 | $5,863 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 42 | $6,813 | $3,835 | 56.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 18 | 19 | $6,195 | $3,581 | 57.8% |
About Dr. Brian Fabian, MD
Dr. Brian Fabian, MD is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245362763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Fabian, MD has received a total of $289.24 in payments from pharmaceutical and medical device companies, with $47.49 received in 2024. These payments were reported across 6 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($289.24).
As a Medicare-enrolled provider, Fabian has provided services to 27,398 Medicare beneficiaries, totaling 48,688 services with total Medicare billing of $4.4M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 03/10/2007
- Last Updated 09/16/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1245362763
Products in Payments
- VALCHLOR (Drug) $125.00
- Apligraf (Device) $79.81
- Kerecis Omega3 SurgiClose (Device) $26.83
- AMELUZ (Drug) $20.66
- EUCRISA (Drug) $20.16
- BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device) $16.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dr. Douglas Robins, Md, MD
Dermatology — Payments: $24,873
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036